UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 117 filers reported holding UROGEN PHARMA LTD in Q2 2024. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $860,000 | – | 18,200 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 873,424 | $7,608,000 | 1.84% |
| Wildcat Capital Management, LLC | 533,139 | $4,644,000 | 1.19% |
| Stonepine Capital Management, LLC | 268,833 | $2,342,000 | 0.97% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,952,489 | $25,716,000 | 0.37% |
| Annandale Capital, LLC | 84,331 | $735,000 | 0.29% |
| Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. | 25,330 | $219,000 | 0.17% |
| RTW INVESTMENTS, LP | 857,464 | $7,469,000 | 0.16% |
| Harel Insurance Investments & Financial Services Ltd. | 1,025,633 | $8,933,000 | 0.15% |
| Migdal Insurance & Financial Holdings Ltd. | 698,302 | $6,082,000 | 0.11% |
| SHIKIAR ASSET MANAGEMENT INC | 33,250 | $290,000 | 0.08% |